You may qualify to participate in an international research study to evaluate the safety and tolerability of an investigational drug for patients with type 2 diabetes and kidney disease. Are you at least 18 years old? Do you have type 2 diabetes mellitus and a clinical diagnosis of kidney disease? Eligible study participants will receive study medications, blood pressure checks, physical exams, laboratory tests and ECG at no cost. Participants will  be reimbursed for time and travel. For more information, call the UAB Hypertension Program at 934-9281 or e-mail ccc-hlnresearch@mail.ad.uab.edu.
The UAB Department of Nutrition Sciences, is conducting a 29-week research study to evaluate the effectiveness of an investigational drug to treat Type 2 DM. To qualify, you must be age 18 or older with Type 2 Diabetes, taking an SGLT-2 alone or in combination with a stable daily dose of Metformin to control your blood sugars. Qualified participants will receive study drug, diet/exercise counseling, EKG, physical and diabetic supplies. There is no charge for participation. Compensation for time and travel may also be available. For more information, and to see if you might be eligible to join, please contact (205) 996-4015 or (205) 996-4020.
You may qualify if you ages 19-45, are African American or European American,  do not have diabetes, exercise less than 2 hours per week, and are willing to travel to UAB for screening and 4 testing visits. Participants will receive their blood sugar level, cholesterol level, bone density, fat mass, and muscle mass. Compensation up to $400 provided for completing all study visits. Please call 934-4386 for more information.